Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.41
-0.04 (-0.73%)
At close: Mar 6, 2026, 4:00 PM EST
5.32
-0.09 (-1.66%)
After-hours: Mar 6, 2026, 7:36 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $175.94 million as of March 6, 2026. Its market cap has increased by 35.77% in one year.
Market Cap
175.94M
Enterprise Value
50.56M
1-Year Change
35.77%
Ranking
Category
Stock Price
$5.41
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $175.94M, a decrease of -50.41%. That is a compound annual growth rate of -23.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 175.94M | -8.61% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 183.78M |
| NeOnc Technologies Holdings | 183.64M |
| SAB Biotherapeutics | 181.38M |
| Kalaris Therapeutics | 180.95M |
| Cartesian Therapeutics | 178.90M |
| ProQR Therapeutics | 178.03M |
| Canton Strategic Holdings | 177.88M |
| Tenaya Therapeutics | 177.38M |